TD Cowen analyst Gary Taylor upgraded Surgery Partners to Outperform from Market Perform with a price target of $35, down from $39.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SGRY:
- Surgery Partners price target lowered to $42 from $50 at Mizuho
- Surgery Partners price target lowered to $43 from $47 at Citi
- Surgery Partners, Inc. Announces Third Quarter 2023 Results
- Surgery Partners sees 2023 revenue $2.75B, consensus $2.76B
- Surgery Partners reports Q3 adjusted EPS 19c, consensus 16c